MarginsXMarginsX
Home › Markets › Health Care › QNRX

Quoin Pharmaceuticals Ltd. (QNRX)

QNRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.56
-3.78% on the day
Market cap
$17.1M
Nano cap
Revenue · 2021
$0
Prior year not contiguous
Net income · 2021
-$21.5M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2021-12-31, https://www.sec.gov/Archives/edgar/data/1671502/000110465922045620/0001104659-22-045620-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2021-12-31.

Profile

FieldValue
TickerQNRX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryIsrael
IPO year2016
SEC CIK0001671502
SEC industry codePharmaceutical Preparations
Incorporated inIsrael

Financials · 2021

LineValue
Revenue$0
Net income-$21.5M
Operating incomeNot in SEC XBRL data
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$7.5M
Total assets$9.4M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
6.4 months
$10.1M cash at September 30, 2026
Share count, 1 year
+472.6%
2025-10-31 to 2026-11-02
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$309K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$10.1M cash; operating cash flow -$4.7M a quarter.Report 2026-09-30
Shares outstandingNo cover-page share count in XBRLCover page 2026-11-02
Reverse splits, 3 years1; latest 1-for-35 on 2025-04-09Source 2025-04-09
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-11-04
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCBIZ CPAs P.C., Morristown, New Jersey, United States; changed auditors 1 time in 24 months8-K 4.01 2025-03-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $309K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$4.9M-$5.8M$10.1MNo debt tagsNeeds four quarters10-Q 2026-11-05
Q2 2026
2026-06-30
Not filed-$5.4M-$3.1M$3.8MNo debt tagsNeeds four quarters10-Q 2026-11-05
Q1 2026
2026-03-31
Not filed-$5.0M-$4.9M$3.1MNo debt tagsNeeds four quarters10-Q 2026-11-05
Q4 2025
2025-12-31
Not filed-$4.3M-$5.0M$3.8MNo debt tagsNeeds four quarters10-K 2026-03-26
Q3 2025
2025-09-30
Not filed-$3.9M-$2.2M$1.8MNo debt tagsNeeds four quarters10-Q 2026-11-05
Q2 2025
2025-06-30
Not filed-$3.7M-$3.7M$1.7MNo debt tagsNeeds four quarters10-Q 2026-11-05
Q1 2025
2025-03-31
Not filed-$3.8M-$2.6M$3.8MNo debt tagsNeeds four quarters10-Q 2026-11-05
Q4 2024
2024-12-31
Not filed-$2.3M-$2.2M$3.6MNo debt tagsNeeds four quarters10-K 2026-03-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-11-04
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-11-05
Latest current report
FORM 8-K
8-K2026-11-12
Latest proxyDEF 14A2026-10-02

Source: SEC EDGAR submissions feed, 587 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.4%
1 month-10.8%
3 months-38.8%
Year to date-74.4%
1 year-72.4%
From 52-week high-83.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
KTTAPasithea Therapeutics Corp.$0.5000-4.21%$16.7M
LPCNLipocine Inc.$1.66-2.92%$18.4M
NCELNewcelX Ltd.$2.75+5.36%$15.9M
COCPCocrystal Pharma Inc.$0.9777-0.24%$18.8M
CNTXContext Therapeutics Inc.$0.1659-8.24%$15.2M
ATOSAtossa Therapeutics Inc.$1.93-1.53%$19.3M
AKTXAkari Therapeutics plc ADS$6.51-4.26%$15.1M
BOLTBolt Biotherapeutics Inc.$5.80-4.61%$15.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier